Enrui Kainuo Biotechnology

Nanjing Enrui Kainuo Biotechnology Co., Ltd, a China-based cell therapy developer, has reportedly raised tens of millions of renminbi in a pre-Series A financing round. The round was led by Watere Capital, with participation from Future Invest. The funds raised will be directed towards IND filings, advancing the product pipeline,…